Jürgen Finke Selected Research

Thiotepa (Triethylenethiophosphoramide)

11/2017	Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.
1/2017	Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia-A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
8/2016	High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.
5/2016	Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
9/2012	Radiation-free allogeneic conditioning with fludarabine, carmustine, and thiotepa for acute lymphoblastic leukemia and other hematologic malignancies necessitating enhanced central nervous system activity.
1/2008	High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.
8/2006	High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jürgen Finke Research Topics

Disease

41	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 02/2003
39	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2022 - 01/2007
38	Leukemia 01/2022 - 11/2004
37	Neoplasms (Cancer) 06/2022 - 09/2002
23	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 06/2002
20	Lymphoma (Lymphomas) 01/2022 - 06/2003
10	Bronchiolitis Obliterans Syndrome 01/2022 - 03/2009
9	Multiple Myeloma 01/2022 - 02/2006
9	Primary Myelofibrosis (Myelosclerosis) 12/2021 - 10/2016
9	Hematologic Neoplasms (Hematological Malignancy) 11/2021 - 09/2002
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 02/2007
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 08/2002
4	Residual Neoplasm 10/2020 - 06/2005
4	Infections 01/2020 - 02/2002
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2022 - 01/2017
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 09/2003
3	Cytopenia 01/2020 - 10/2016
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 06/2012
3	Neutropenia 01/2020 - 02/2002
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2019 - 11/2006
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 08/2016
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2018 - 06/2003
3	Myeloid Leukemia (Leukemia, Myelocytic) 06/2012 - 04/2003
2	Pathologic Complete Response 01/2022 - 02/2012
2	Polycythemia Vera 11/2020 - 01/2019
2	Essential Thrombocythemia 11/2020 - 01/2019
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2020 - 07/2007
2	Hematologic Diseases (Blood Diseases) 10/2019 - 01/2019
2	Virus Diseases (Viral Diseases) 02/2015 - 08/2005
2	Refractory Anemia 10/2014 - 06/2012
2	Thrombocytopenia (Thrombopenia) 07/2007 - 02/2002
2	Disease Progression 08/2006 - 08/2005
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021
1	Splenomegaly 01/2021
1	Immune System Diseases (Immune Disorders) 01/2021
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020

Drug/Important Bio-Agent (IBA)

12	Methotrexate (Mexate)FDA LinkGeneric 02/2019 - 04/2003
8	fludarabineIBA 01/2022 - 09/2002
8	Carmustine (FIVB)FDA Link 08/2016 - 09/2002
7	Thomsen-Friedenreich antibodiesIBA 01/2020 - 02/2003
7	GlobulinsIBA 01/2020 - 02/2003
7	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2019 - 04/2003
7	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 11/2017 - 08/2006
6	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 09/2002
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 09/2015
5	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2017 - 08/2006
4	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 08/2005
4	Tyrosine Kinase InhibitorsIBA 10/2019 - 09/2014
4	Rituximab (Mabthera)FDA Link 11/2017 - 05/2016
3	Busulfan (Busulfex)FDA Link 01/2022 - 09/2015
3	treosulfanIBA 01/2022 - 01/2020
3	ruxolitinibIBA 12/2021 - 11/2018
3	Cell-Free Nucleic AcidsIBA 10/2021 - 02/2018
3	AntigensIBA 01/2021 - 02/2003
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 04/2006
3	Sorafenib (BAY 43-9006)FDA Link 10/2020 - 01/2018
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 01/2016
3	HLA Antigens (Human Leukocyte Antigens)IBA 03/2015 - 08/2006
3	Alemtuzumab (Campath)FDA Link 10/2013 - 08/2009
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 08/2021 - 04/2003
2	ibrutinibIBA 01/2020 - 01/2019
2	Inosine Triphosphate (ITP)IBA 01/2020 - 07/2007
2	SteroidsIBA 11/2018 - 08/2009
2	Interleukin-15 (Interleukin 15)IBA 04/2018 - 01/2018
2	Azacitidine (5 Azacytidine)FDA Link 01/2018 - 09/2012
2	CytokinesIBA 06/2014 - 09/2004
2	Granzymes (Granzyme)IBA 12/2013 - 09/2008
2	Monoclonal AntibodiesIBA 10/2013 - 11/2012
2	HLA-B Antigens (HLA-B)IBA 11/2012 - 02/2003
2	HLA-A Antigens (HLA-A)IBA 11/2012 - 02/2003
2	HLA-DRB1 Chains (HLA DRB1)IBA 11/2012 - 02/2003
2	HLA-DQB1 antigen (HLA DQB1)IBA 11/2012 - 02/2003
2	Lenalidomide (CC 5013)FDA Link 09/2012 - 02/2012
2	Budesonide (Pulmicort)FDA LinkGeneric 01/2012 - 03/2009
2	Interleukin-8 (Interleukin 8)IBA 10/2004 - 09/2004
1	daratumumabIBA 01/2022
1	Alkylating AgentsIBA 01/2022
1	Janus Kinase InhibitorsIBA 12/2021
1	Core Binding Factor Alpha 2 SubunitIBA 10/2021
1	Calcineurin InhibitorsIBA 08/2021
1	Everolimus FDA Link 08/2021
1	AlgiporeIBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	fms-Like Tyrosine Kinase 3IBA 10/2020
1	Ferritins (Ferritin)IBA 01/2020

Therapy/Procedure

65	Stem Cell Transplantation 10/2022 - 02/2002
53	Cell Transplantation 10/2022 - 05/2005
42	Transplantation 10/2022 - 06/2002
35	Hematopoietic Stem Cell Transplantation 01/2022 - 04/2003
21	Therapeutics 01/2022 - 02/2002
12	Homologous Transplantation 01/2022 - 09/2002
9	Drug Therapy (Chemotherapy) 11/2021 - 03/2006
6	Radiotherapy 11/2017 - 06/2003
5	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2016 - 09/2002
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 01/2018
2	Immunotherapy 11/2012 - 01/2007
2	Induction Chemotherapy 09/2008 - 01/2008
1	Splenectomy 01/2021